APLN and obesity due to melanocortin 4 receptor deficiency: Consistent with this view, recent work in our laboratory has shown that therapeutic natural and stable analogues of apelin-13 stimulate insulin secretion, enhance cellular glucose uptake and improve acute glucose tolerance in animal models of obesity-diabetes [27,34].